Alfieri AB, Cubeddu LX.
Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients.
Br J Cancer. 1995 ;72:1013-5.
Management of radiation-induced nausea and vomiting.
Exp Hematol 2007; 35:34–36, 2007
Alexander E 3rd, Siddon RL, Loeffler JS.
The acute onset of nausea and vomiting following stereotactic radiosurgery: correlation with total dose to area postrema.
Surg Neurol. 1989 ;32:40-4.
Basch E, Prestrud AA, Hesketh PJ et al.
Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
J Clin Oncol. 2011 ;29:4189-98.
Casey DL, Wexler LH, LaQuaglia MP et al.
Favorable outcomes after whole abdominopelvic radiation therapy for pediatric and young adult sarcoma.
Pediatr Blood Cancer 2014; 61:1565–1569
Cox MC, Kusters JM, Gidding CE et al.
Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
Radiat Oncol. 2015 ;10:241.
Chow E, Meyer RM, Ding K et al.
Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
Lancet Oncol 2015; 16:1463–1472.
Ciura K, McBurney M, Nguyen B et al.
Effect of brain stem and dorsal vagus complex dosimetry on nausea and vomiting in head and neck intensity-modulated radiation therapy.
Med Dosim. 2011 Spring;36:41-5.
Danjoux CE, Rider WD, Fitzpatrick PJ.
The acute radiation syndrome. A memorial to William Michael Court-Brown.
Clin Radiol 1979; 30:581–584.
Dennis K, Zhang L, Lutz S et al.
International patterns of practice in the management of radiation therapy-induced nausea and vomiting.
Int J Radiat Oncol Biol Phys 2012; 84:e49-60.
Dennis K , De Angelis C, Jon F et al.
Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study.
Curr Oncol. 2014 ;21: e760-7.
Dupuis LL, Nathan PC.
Optimizing emetic control in children receiving antineoplastic therapy: beyond the guidelines.
Paediatr Drugs. 2010;12:51-61.
Chemotherapy-induced vomiting in children: some progress, more questions.
Lancet Oncol 2016; 17:264–265.
Dupuis LL, Sung L, Molassiotis A et al.
2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children.
Support Care Cancer. 2017; 25:323-331.
Dupuis LL, Boodhan S, Sung L et al.
Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients.
Pediatr Blood Cancer . 2011; 57:191–198
Dupuis LL, Robinson PD, Boodhan S et al.
Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients.
Pediatr Blood Cancer . 2014; 61:1506–1512.
Dupuis LL, Boodhan S, Holdsworth M et al.
Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.
Pediatr Blood Cancer . 2013; 60:1073–1082.
Emami H, Hematti S, Saeidian SM et al.
The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting.
J Res Med Sci . 2015; 20:329–333.
Enblom A, Bergius Axelsson B et al.
One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer. 2009; 17:23–32.
Feyer PC, Maranzano E, Molassiotis A et al.
Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009. Support Care Cancer. 2011; 19 Suppl 1:S5-14.
Feyer PC, Stewart AL, Titlbach OJ.
Aetiology and prevention of emesis induced by radiotherapy.
Support Care Cancer. 1998 ;6:253-60.
Feyer P, Jahn F, Jordan K.
Prophylactic Management of Radiation-Induced Nausea and Vomiting.
BioMed Res Int 2015 ; 2015:893013.
Franzén L, Nyman J, Hagberg H et al.
A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy.
Ann Oncol 1996; 7:587–592.
Gore L Chawla S, Petrilli A et al.
Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo- controlled study of efficacy and tolerability.
Pediatr Blood Cancer. 2009 ;52:242-7.
Hesketh PJ, Kris MG, Grunberg SM et al.
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
J Clin Oncol. 1997; 15:103–109, 1997
Chemotherapy-induced nausea and vomiting.
N Engl J Med; 2008; 358:2482–2494.
Huang SC, Korlipara VL.
Neurokinin-1 receptor antagonists: a comprehensive patent survey.
Expert Opin Ther Pat. 2010 ;20:1019-45.
Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?
Int J Radiat Oncol Biol Phys. 2004; 60:1018–1025.
Jahn F, Riesner A, Jahn P et al.
Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin.
Int J Radiat Oncol Biol Phys. 2015; 92:1101–1107.
Jordan K, Roila F, Molassiotis A et al.
Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009.
Support Care Cancer. 2011; 19 Suppl 1:S37-42.
Jordan K, Schmoll HJ, Aapro MS. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol. 2007 ;61:162-75.
Kocak-Uzel E, Gunn GB, Colen RR et al.
Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy.
Radiother Oncol. 2014; 111:281–288.
Kovács G, Wachtel AE, Basharova EV et al.
Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study.
Lancet Oncol. 2016 ;17:332-44.
Kusnierczyk NM, Saunders EF, Dupuis LL.
Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation.
Bone Marrow Transplant. 2002; 30:119–124.
Law A, Kennedy T, Pellitteri P et al.
Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Int J Radiat Oncol Biol Phys. 2007; 69:1361–1368.
Lee VHF, Ng SCY, Leung TW et al.
Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer. Int J Radiat Oncol Biol Phys. 2012; 84:176–182.
Maranzano E, De Angelis V, Pergolizzi S et al.
A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres.
Radiother Oncol. 2010; 94:36–41.
Monroe AT, Reddy SC, Gibbs GL et al.
Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy.
Radiother Oncol. 2008; 87:188–194.
Morrow GR, Roscoe JA, Hynes HE et al.
Progress in reducing anticipatory nausea and vomiting : a study of community practice.
Support Care Cancer.1998; 6:46–50.
Morrow GR, Hickok JT, Burish TG et al.
Frequency and clinical implications of delayed nausea and delayed emesis.
Am J Clin Oncol 1996; 19:199–203.
Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and Vomiting.
BioMed Res Int. 2015; 2015:595894
Navari RM, Aapro M.
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.
N Engl J Med. 2016 : 374:1356–1367.
Navari RM, Qin R, Ruddy KJ et al.
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
N Engl J Med. 2016 ;375:134–142.
Noël G, Antoni D, Barillot I et al.
Delineation of organs at risk and dose constraints Cancer Radiother . 2016 ; 20 Suppl:S36-60.
Phillips RS, Gopaul S, Gibson F et al.
Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood. Cochrane Database Syst Rev.2010 ;9:CD007786.
Poon M, Hwang J, Dennis K et al.
A novel prospective descriptive analysis of nausea and vomiting among patients receiving gastrointestinal radiation therapy.
Support Care Cancer . 2016 ; 24:1545–1561.
Priestman TJ, Roberts JT, Upadhyaya BK.
A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy.
Clin Oncol (R Coll Radiol) .1993; 5:358–363.
Roila F, Herrstedt J, Gralla RJ et al.
Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference.
Support Care Cancer. 2011; 19 Suppl 1:S63-65.
Roila F, Molassiotis A, Herrstedt J et al.
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.
Ann Oncol. 2016; 27:v119–v133.
Roscoe JA, Bushunow P, Jean-Pierre P et al.
Acupressure bands are effective in reducing radiation therapy-related nausea.
J Pain Symptom Manage. 2009 ; 38:381–389.
Rosenthal DI, Chambers MS, Fuller CD et al.
Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer.
Int J Radiat Oncol Biol Phys. 2008; 72:747–755.
Ruhlmann CH, Jahn F, Jordan K et al.
2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.
Support Care Cancer.2017 ;25:309-316.
Seynaeve C, Schuller J, Buser K et al.
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-
blind, randomised, parallel group study. Ondansetron Study Group.
Br J Cancer. 1992 ;66:192-7.
Spitzer TR, Friedman CJ, Bushnell W et al.
Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Bone Marrow Transplant . 2000; 26:203–210.
The Italian Group for Antiemetic Research in Radiotherapy.
Radiation-induced emesis: a prospective observational multicenter Italian trial.
Int J Radiat Oncol Biol Phys. 1999; 44:619–625.
Vidall C, Fernández-Ortega P, Cortinovis D et al.
Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and
the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
Support Care Cancer. 2015 ;23:3297-305.